I listened to the conference.
No need for questions because two - maybe three - major investors own the vast majority of stock - and they can get all their questions answered whenever they want. No need to wait for the ASM. By my estimation, of the 170,000,000 shares outstanding, I have them owning roughly 150,000,000 shares. They now control the stock. And it, of course, behooves them to see the stock rise.
Currently the market cap is a paltry 1.36M. Ironically this is the furthest Rock Creek has ever been to bringing a drug to the market. Don't get me wrong, they still have a long ways to go, however for a few speculators, this price level (however it got there <cough, cough>) made sense so they bought in. Besides, they OWN the company NOW. What else can they do but stick around - or sell once they ramp it up / good news is finally delivered . . .
This is only my opinion only, and it should not be construed as investment advice.
